Bristol-Myers Squibb Co (BMY)

Get Bristol-Myers Squibb Co (BMY) share price news and insights for better trading strategies. Stay informed with FP Markets Ethiopia.

Pricing is indicative. Past performance is not a reliable indicator of future results. Log in to see latest markets data.

Bristol-Myers Squibb Co (BMY) Profile

Biopharmaceutical products are developed, manufactured and marketed by Bristol-Myers Squibb. The company sells products in hematology, oncology, cardiology, and immunology. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma, Opdivo, an anti-cancer drug, Eliquis, an oral inhibitor for the prevention of stroke/systemic embolism in patients with NVAF, and Orencia, for the management of DVT/PE in adults. It also offers Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia, Yervoy for unresectable or metastatic melanoma, Abraxane, a protein-bound chemotherapeutic product, mpliciti for multiple myeloma, and Reblozyl for anemia in adult beta thalassemia sufferers. It also offers Onureg for AML, Zeposia for relapsing MS, Vidaza for MDS subtypes, Baraclude, an oral antiviral for chronic hepatitis B, and Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for relapsed or refractory large B-cell lymphoma. Companies such as this one sell to hospitals and government agencies as well as wholesalers. • Pfizer; Otsuka; Ono; Nektar; AVEO; Huyabio; Darwin Health; Inspirna; and Bolt Biotherapeutics; Originally known as Bristol-Myers Squibb. Bristol-Myers Squibb is headquartered in New York, New York.

Full Time Employees: 30,250. Latest stock price 64.72-0.17 (-0.26%) At close: 04:00PM EST.19th January 2022, Total assets for the quarter ending September 30, 2021 were $110.893B, Subsidiaries: Celgene, MyoKardia, Inc., Juno Therapeutics, Union de Pharmacologie Scientifique Appliquée, Bristol Myers Squibb Pharmaceuticals and more.

Bristol-Myers Squibb Co (BMY.xnys) Analysis
Thu, January 20, 2022, 5:50 AM Bristol Myers Squibb (BMY) closed the most recent trading day at $64.72, moving -0.26% from the previous trading session. This change was narrower than the S&P 500's daily loss of 0.97%. Meanwhile, the Dow lost 0.96%, and the Nasdaq, a tech-heavy index, added 0.23%.

Start Trading Bristol-Myers Squibb Co (BMY) with a Market Leader Today

Bristol-Myers Squibb Co (BMY) Trading FAQ

Shares represent units of ownership within a company. Shares are also known as stocks or equities. Dividend payments are common with some companies, a method of sharing company profits with shareholders. In addition to traditional share dealing, however, traders can access derivatives: trading instruments derived from the movement of an underlying share price.

Individual stock CFDs (contract for differences) fall under the umbrella of derivative products, an effective low-cost trading vehicle. While CFDs do not grant shareholder privileges, active CFD positions may receive a dividend if executed before the ex-dividend date.

Start Trading
in minutes

Get instant Updates in Telegram